Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelodysplastic Syndrome With Excess Blasts”

343 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 343 results

Testing effectiveness (Phase 2)Study completedNCT00309842
What this trial is testing

Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Masonic Cancer Center, University of Minnesota 213
Not applicableLooking for participantsNCT06111612
What this trial is testing

Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvement

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic NeoplasmChronic Myelomonocytic Leukemia+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Early research (Phase 1)Study completedNCT00606437
What this trial is testing

Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants

Who this might be right for
LymphomaMyelomaLeukemia+4 more
Duke University 40
Early research (Phase 1)Ended earlyNCT00234000
What this trial is testing

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Jonsson Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)Ended earlyNCT00740181
What this trial is testing

Decitabine, Cytarabine, GCSF for Refractory AML/MDS

Who this might be right for
MyelodysplasiaLeukemia
Brown University 9
Testing effectiveness (Phase 2)Study completedNCT00357565
What this trial is testing

Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia

Who this might be right for
LeukemiaMyelodysplastic SyndromesChildhood Acute Myeloid Leukemia in Remission+10 more
Masonic Cancer Center, University of Minnesota 34
Testing effectiveness (Phase 2)Study completedNCT00002547
What this trial is testing

Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Barbara Ann Karmanos Cancer Institute 280
Not applicableLooking for participantsNCT04800458
What this trial is testing

Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis

Who this might be right for
ThrombocytopeniaImmune ThrombocytopeniaMyelodysplasia
University Hospital, Bordeaux 225
Testing effectiveness (Phase 2)Study completedNCT01297543
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+1 more
Cellerant Therapeutics 45
Testing effectiveness (Phase 2)Study completedNCT01772420
What this trial is testing

Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia

Who this might be right for
Adult Myelodysplastic SyndromeAnemiaChronic Myelomonocytic Leukemia
Albert Einstein College of Medicine 52
Large-scale testing (Phase 3)Study completedNCT00354120
What this trial is testing

Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant

Who this might be right for
Acute Myeloblastic LeukemiaLymphoblastic LeukemiaMyelodysplasia+3 more
Gruppo Italiano Trapianto di Midollo Osseo 121
Testing effectiveness (Phase 2)Study completedNCT01203722
What this trial is testing

Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 87
Testing effectiveness (Phase 2)Study completedNCT00627666
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Asan Medical Center 52
Early research (Phase 1)Ended earlyNCT03320642
What this trial is testing

GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

Who this might be right for
Hematologic Malignancies
Incyte Corporation 84
Not applicableStudy completedNCT05260203
What this trial is testing

MargheRITA (Remote Intelligence for Therapeutic Adherence)

Who this might be right for
Multiple MyelomaSolitary PlasmacytomaAmyloidosis+11 more
Advice Pharma Group srl 124
Large-scale testing (Phase 3)Study completedNCT01295710
What this trial is testing

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Who this might be right for
GVHDAdult Acute Myeloid LeukemiaAdult Acute Lymphoid Leukemia+1 more
Neovii Biotech 260
Testing effectiveness (Phase 2)Study completedNCT00074074
What this trial is testing

Infliximab in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC 46
Testing effectiveness (Phase 2)Ended earlyNCT03593915
What this trial is testing

A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS

Who this might be right for
Myelodysplastic Syndromes (MDS)
Sumitomo Pharma America, Inc. 20
Early research (Phase 1)Study completedNCT01139151
What this trial is testing

4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 31
Not applicableLooking for participantsNCT07511829
What this trial is testing

WearAble Technology for Collecting Health Data in People Who Are the Transfused (WATCH Transfused) - A UK Exploratory Study to Improve Quality of Life and the Efficacy of Transfusion Supportive Care in People With Blood Cancers Undergoing Treatment

Who this might be right for
MDS (Myelodysplastic Syndrome)AML (Acute Myeloid Leukemia)
University of Oxford 80
Next Page